Doug Hampton

Cynosure and Lutronic Announce Merger to Create a Leading Global Medical Aesthetics Technology Company

by

WESTFORD, Mass. and BILLERICA, Mass., Jan. 19, 2024 /PRNewswire/ — Cynosure and Hahn & Company, which has recently acquired Lutronic, announced today that they have entered into a definitive merger agreement for a strategic combination of Cynosure and Lutronic. Both Cynosure and Lutronic are global providers of energy-based medical aesthetic treatment systems and related technologies. … Read more

Global Bioanalytical Testing Services Market Set to Double, Reaching $6.6 Billion by 2028, BCC Research Study Finds

by

Latest BCC Research Report Predicts a Robust 15.2% CAGR for Bioanalytical Testing Services, Expanding from $3.2 Billion in 2023  BOSTON, Jan. 18, 2024 /PRNewswire/ — The Global Bioanalytical Testing Services Market is a dynamic and essential sector within the healthcare and pharmaceutical industries. Focused on evaluating and interpreting biological substances, these services play a critical … Read more

Veeva finalise la migration des études vers Veeva Vault EDC pour une entreprise biopharmaceutique de premier plan

by

Pour la première fois dans l’industrie, toutes les études en cours ont été transférées de l’ancien EDC vers Vault EDC. BARCELONE, Espagne, 17 janvier 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a annoncé aujourd’hui que l’une des 20 plus grandes entreprises biopharmaceutiques et Veeva Services ont migré 25 études cliniques en cours vers Veeva Vault EDC à partir d’une ancienne … Read more

Auburn Engineering faculty start-up VivoSphere™ nominated for prestigious Ignite Award

by

AUBURN, Ala., Jan. 16, 2024 /PRNewswire/ — VivoSphere, a biomedical engineering start-up founded by two Auburn University chemical engineering researchers that created a precise, cost-effective test bed for high-throughput, pre-clinical evaluation of critical cancer therapy candidates, has been selected as one of the most promising new ventures in the bio-diagnostics industry. The New Venture Accelerator company was nominated … Read more

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

by

HSINCHU, Jan. 15, 2024 /PRNewswire/ — Brain Navi announced the completion of the 100th case utilizing its neurosurgical navigation robot NaoTrac. The 100th case has been performed by Neurosurgery Department Director Dr. Hao-Yu Chuang at Annan Hospital in Tainan, Taiwan. Brain Navi Completed 100th Surgical Procedure Using NaoTrac “It is my pleasure to be witnessing this … Read more

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox

by

STOCKHOLM, Jan. 15, 2024 /PRNewswire/ — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that clinical pharmacokinetic (PK) data from the first study with fostroxacitabine bralpamide (fostrox) (NCT03781934) will be presented at the European Association for the Study of … Read more

Extracorporeal Membrane Oxygenation Machines Market size to grow by 640.24 million by 2027 with a CAGR of 10.05 between 2022 – 2027

by

NEW YORK, Jan. 11, 2024 /PRNewswire/ — The extracorporeal membrane oxygenation machines market is expected to grow by USD 243.6 million from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 10.05% during the forecast period, according to Technavio Research.  Technavio has announced its latest market research report titled Global Extracorporeal Membrane … Read more

Mobile Grooming Offers Safe Solution for Dogs Amidst Mysterious Respiratory Illness Outbreak

by

LIVONIA, Mich., Jan. 10, 2024 /PRNewswire/ — The recent outbreak of a mysterious respiratory illness among dogs in the United States has caused concern among pet owners and veterinary experts. With cases reported in over 16 states, including California, Florida, and Massachusetts, there is a growing need for solutions to keep dogs safe. That’s where … Read more

Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.

by

TOKYO, Jan. 8, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter on January 4, 2024, regarding the Biologics License Application (BLA) for zolbetuximab, an investigational agent for the treatment of patients with locally advanced unresectable … Read more

Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023

by

SINGAPORE, Jan. 7, 2024 /PRNewswire/ — Juniper Biologics (“Juniper“), a global science-led pharmaceutical company headquartered in Singapore, proudly announces its latest achievement, winning the award for Molecular Science & Technology Acquisition of the Year at Acquisition International’s M&A Awards 2023. This recognition highlights Juniper’s unwavering commitment to advancing treatments in oncology-supportive care and its overarching mission … Read more